<DOC>
	<DOC>NCT00099242</DOC>
	<brief_summary>The goal of this research study is to evaluate the safety and efficacy of the rivastigmine transdermal patch in patients with probable Alzheimer's Disease.</brief_summary>
	<brief_title>Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Rivastigmine</mesh_term>
	<criteria>Diagnosis of dementia of the Alzheimer's type Males, and females who are surgically sterile or one year postmenopausal A primary caregiver willing to accept responsibility for supervising the treatment Any condition (other than Alzheimer's) that could explain patient's dementia An advanced, severe or unstable disease that may put the patient at special risk Current diagnosis of active, uncontrolled seizure disorder or unstable cardiovascular disease</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Alzheimer's Disease</keyword>
	<keyword>Dementia</keyword>
</DOC>